Can a tiny ear tube offer lasting relief for middle ear infections?

NCT ID NCT07029997

Recruiting now Disease control Sponsor: AventaMed DAC Source: ClinicalTrials.gov ↗

First seen Aug 13, 2026 · Last updated Aug 14, 2026 · Updated 1 time

Summary

This study is checking how well the Solo+ tympanostomy tube works in people with middle ear infections. Researchers will review doctor notes, monitor how the tubes function after surgery, and ask patients or their parents about their experience. The goal is to gather real-world information on the device's performance and safety in both people who have already had the procedure and those who are scheduled for it.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Solo+ Tympanostomy Tube Device
What this could lead to: If successful, this could confirm the Solo+ ear tube as a reliable, safe option for managing recurrent middle ear infections, potentially reducing the need for repeat procedures.
What could go wrong: This is a post-market observational study, not a randomized trial, so it cannot prove the device is better than alternatives. Risks include tube blockage, early extrusion, or procedure-related complications.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MIDDLE EAR INFECTIONS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

infectious otitis media otitis media

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

MIDDLE EAR INFECTIONS OTITIS MEDIA

Contacts and locations

Locations

I.R.C.C.S. Materno Infantile Burlo Garofolo
RECRUITING

Trieste, Trieste (TS), 6534137, Italy

More trials for these conditions

Other studies related to the condition(s) this trial covers.